Halaman 3 - Kanker hati stadium 2 Dokter Terbaik - TOP-90 dokter

Seorang spesialis terkemuka dalam prosedur Whipple dan bedah perut invasif minimal, Dr. Greenberg mengepalai Departemen Bedah Kolorektal di Sourasky Medical Center (Ichilov).

• Memiliki pengalaman lebih dari 20 tahun sebagai ahli bedah perut
• Melakukan teknik bedah terbuka maupun invasif minimal
• Ahli dalam prosedur kompleks pankreas dan hati seperti operasi Whipple
• Memimpin departemen bedah khusus di rumah sakit besar

Berpengalaman lebih dari 28 tahun dalam spesialisasi bedah kanker hati – Dr. Ben-haim adalah salah satu ahli bedah kanker gastrointestinal terkemuka di Israel yang bertugas di Sourasky Medical Center.

• Menjadi ahli dalam operasi Whipple untuk kasus-kasus kompleks
• Berfokus secara eksklusif pada kanker hati, pankreas, dan gastrointestinal
• Melakukan intervensi tingkat lanjut untuk kondisi onkologi

Univ. Prof. Dr. Wolfgang Köstler adalah seorang onkolog medis terkemuka yang memelopori terapi target – sebuah strategi inti untuk mengobati berbagai jenis kanker hati saat ini.

• Lebih dari 20 tahun pengalaman klinis, akademik, dan penelitian di bidang onkologi
• Wakil Kepala Divisi Klinis Onkologi di Medical University of Vienna
• Keahlian dalam terapi sistemik individual dan imunoterapi
• Berfokus pada pengembangan biomarker dan strategi onkologi presisi

Prof. Oldhafer adalah spesialis dalam bedah kanker hati di Rumah Sakit Asklepios Barmbek, di mana beliau memimpin Pusat Penyakit Hati.

• Ahli dalam bedah hati dengan navigasi komputer
• Melakukan bedah perut invasif minimal
• Menggunakan teknik canggih seperti pisau ultrasonik
• Berkolaborasi dengan spesialis onkologi dan radiologi

Professor Madya Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal, merawat pasien di Rumah Sakit Universitas Istinye Liv.

• Spesialis Penyakit Dalam dengan pengalaman di berbagai rumah sakit di Turki
• Onkolog di Klinik Onkologi Ankara dan Rumah Sakit Pelatihan dan Penelitian Regional Erzurum
• Menempuh pendidikan kedokteran di Universitas Selcuk di Konya
• Promosi menjadi Professor Madya pada tahun 2016

Associate Professor Dr. Yusuf Acikgoz membawa keahlian khusus dalam Onkologi Medis, dengan pelatihan di Ohio State University dan keterlibatan aktif dalam uji klinis internasional.

• Berpartisipasi dalam uji klinis Fase III seperti CheckMate-649 dan Fortitude-101
• Menjadi anggota ASCO dan Turkish Society of Medical Oncology
• Menerima pelatihan imuno-onkologi melalui kursus CECOG di Wina
• Tersertifikasi dalam Praktik Klinis yang Baik (GCP) dan Perlindungan Subjek Manusia

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Spesialis dalam bedah laparoskopi dan onkologi dengan pelatihan di Universitas Istanbul. Dr. Al berfokus pada teknik invasif minimal untuk kanker hati.

• Melakukan pelatihan bedah laparoskopi tingkat lanjut di Fakultas Kedokteran Cerrahpaşa
• Melakukan operasi bariatrik dan anti-refluks laparoskopi
• Lulus dari Fakultas Kedokteran Universitas Ondokuz Mayıs
• Mengambil spesialisasi di Fakultas Kedokteran KTÜ, Rumah Sakit Farabi

Dr. Ozden membawa lebih dari 20 tahun keahlian di bidang onkologi, yang diasah melalui berbagai peran klinis di seluruh Turki.

• Spesialisasi dalam onkologi medis dengan fokus pada kanker hati
• Menempuh pendidikan di Fakultas Kedokteran Cerrahpaşa Universitas Istanbul yang ternama
• Pengalaman luas di rumah sakit swasta maupun universitas
• Berkomitmen pada rencana perawatan yang dipersonalisasi untuk setiap pasien

Professor Madya Babek Tabandeh adalah ahli bedah spesialis kanker hati dan teknik bedah invasif minimal. Beliau melakukan operasi hati yang kompleks di Rumah Sakit Medical Park Göztepe.

• Pengalaman lebih dari 25 tahun dalam bedah umum dan kanker
• Fokus pada bedah invasif minimal untuk pemulihan yang lebih baik
• Penulis dengan lebih dari 40 karya ilmiah yang telah dipublikasikan
• Anggota dari American College of Surgeons yang bergengsi
• Juga menjadi anggota Liver Transplantation Society

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Spesialisasi dalam viroterapi – salah satu bidang imunologi terbaru – Dr. Jaunalksne membawa 30+ tahun pengalaman dalam pengobatan kanker hati.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada pendekatan imunologis mutakhir untuk kanker

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center, membawa 33 tahun keahlian onkologi yang terfokus.

• Spesialisasi dalam Onkologi Medis & Radioterapi
• Kepala Pusat Kanker Gastrointestinal di Hadassah
• Tersertifikasi dewan dalam Onkologi & Radioterapi
• Anggota Masyarakat Onkologi Klinis Israel
• Fasih berbahasa Inggris dan Ibrani untuk pasien internasional

Prof. Madya Dr. Nail Paksoy adalah spesialis onkologi medis bersertifikat ESMO di Rumah Sakit Medipol Bahçelievler, spesialis dalam kanker hati dengan pengalaman uji klinis yang luas.

• Menyelesaikan fellowship di Institut Onkologi Universitas Istanbul
• Menjadi sub-peneliti dalam 8 uji klinis onkologi internasional
• Menerbitkan berbagai studi tentang efikasi pengobatan kanker
• Berspesialisasi dalam pendekatan pengobatan yang disesuaikan secara personal

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.